SGMO icon

Sangamo Therapeutics

103 hedge funds and large institutions have $48.4M invested in Sangamo Therapeutics in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 36 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
-26
Holders Change %
-20.16%
% of All Funds
1.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
23
Reduced
36
Closed
40
Calls
$525K
Puts
$1.54M
Net Calls
-$1.02M
Net Calls Change
-$988K
Name Holding Trade Value Shares
Change
Shares
Change %
Balyasny Asset Management
126
Balyasny Asset Management
Illinois
-$11.4K -31,773 Closed
PP
127
Paloma Partners
Connecticut
-$10.6K -29,625 Closed
AQR Capital Management
128
AQR Capital Management
Connecticut
-$10.6K -29,535 Closed
JF
129
Jump Financial
Illinois
-$9.45K -26,383 Closed
SEI Investments
130
SEI Investments
Pennsylvania
-$7.55K -21,047 Closed
ProShare Advisors
131
ProShare Advisors
Maryland
-$7.15K -19,955 Closed
HSBC Holdings
132
HSBC Holdings
United Kingdom
-$7.46K -19,559 Closed
RJA
133
Raymond James & Associates
Florida
-$4.75K -13,250 Closed
Principal Financial Group
134
Principal Financial Group
Iowa
-$4.69K -13,083 Closed
Comerica Bank
135
Comerica Bank
Texas
-$4.48K -12,500 Closed
MSWM
136
McGlone Suttner Wealth Management
Wisconsin
-$6.02K -11,083 Closed
AAS
137
Avantax Advisory Services
Texas
-$3.58K -10,000 Closed
RWMG
138
Redwood Wealth Management Group
New Jersey
-$1.08K -3,000 Closed
HNB
139
Huntington National Bank
Ohio
-$372 -1,038 Closed
AFWM
140
Abich Financial Wealth Management
Virginia
-$150 -418 Closed